The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis

Critical Reviews in Clinical Laboratory Sciences

Volumn 40, Issue 2, 2003, Pages 117-149

  Rettally, Carlos A ^a   Skarda, Shayne ^a   Garza, Mario A ^a   Schenker, Steven ^a   Grendell, James H ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokine; Necrotizing; Pancreatitis; Phospholipase; Polymorphonuclear elastase; Trypsinogen; Trypsinogen activation peptide

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLASE; C REACTIVE PROTEIN; CARBOXYPEPTIDASE B ACTIVATION PEPTIDE; CYTOKINE; ELASTASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PANCREAS ENZYME; PANCREATIC ASSOCIATED PROTEIN; PHOSPHOLIPASE; PROCARBOXYPEPTIDASE B; PROTEIN; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MEDICAL DECISION MAKING; PANCREATITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW;

EID: 0038637809     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/713609331     Document Type: Review

References (97)

1. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis. Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993; 128: 586-90.
2. Imrie CW. Underdiagnosis of acute pancreatitis. Adv Acute Pancreatitis 1997; 1: 3-5.
3. Foitzik T, Klar E, Buhr HJ, et al. Improved survival in necrotizing pancreatitis despite limiting the indications for surgical debridement. Eur J Surg 1995; 161: 187-92.
4. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999; 27: 749-55.
5. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201-5.
6. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77: 1260-4.
7. Corfield AP, Cooper MJ, Williamson RC, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985; 2: 403-7.
8. McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg 1980; 67: 22-5.
9. Heath DI, Imrie CW. The Hong Kong criteria and severity prediction in acute pancreatitis. Int J Pancreatol 1994; 15: 179-85.
10. Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001; 164: 162-170.
11. Ranson JHC, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69-81.
12. Blamey SL, Imrie CW, O'Neill J, et al. Prognostic factors in acute pancreatitis, Gut 1984; 25: 1340-6.
13. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-60.
14. Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177-81.
15. Steinberg WM. Predictors of severity of acute pancreatitis. Gastroenterol Clin North Am 1990; 19: 849-61.
16. rd, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg 1989; 210: 495-503.
17. Balthazar EJ, Ranson JH, Naidich DP, et al. Acute pancreatitis: prognostic value of CT. Radiology 1985; 156: 767-72.
18. London NJ, Neoptolemos JP, Lavelle J, et al. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 1989; 76: 268-72.
19. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-6.
20. Foitzik T, Bassi DG, Schmidt J, et al. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology 1994; 106: 207-14.
21. Schmidt J, Hotz HG, Foitzik T, et al. Intravenous contrast medium aggravates the impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat. Ann Surg 1995; 221: 257-64.
22. Carmona-Sanchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg 2000; 135: 1280-4.
23. van den Biezenbos AR, Kruyt PM, Bosscha K, et al. Added value of CT criteria compared to the clinical SAP score in patients with acute pancreatitis. Abdom Imaging 1998; 23: 622-6.
24. Clavien PA, Hauser H, Meyer P, et al. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. A prospective study of 202 patients. Am J Surg 1988; 155: 457-66.
25. Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology 1994; 193: 297-306.
26. Viedma JA, Perez-Mateo M, Dominguez JE, et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264-1267.
27. Viedma JA, Perez-Mateo M, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35: 822-7.
28. Paajanen H, Laato M, Jaakkola M, et al. Serum turnout necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995; 82: 271-273.
29. Kylanpaa-Back ML, Takala A, Kemppainen E, et al. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001; 88: 222-7.
30. Lempinen M, Kylanpaa-Back ML, Stenman, UH, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem 2001; 47: 2103-7.
31. Rau B, Cebulla M, Uhl W, et al. The clinical value of human pancreas-specific protein procarboxypeptidase B as an indicator of necrosis in acute pancreatitis: comparison to CRP and LDH. Pancreas 1998; 17: 134-9.
32. Gross V, Scholmerich J, Leser HG, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990; 35: 97-105.
33. Uhl W, Buchler M, Malfertheiner P, et al. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-9.
34. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77: 633-8.
35. Pezzilli R, Billi P, Miglioli M, et al. Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis. Dig Dis Sci 1993; 38: 1265-9.
36. Keim V. Loffler HG. Pancreatitis-associated protein in bile acid-induced pancreatitis of the rat. Clin Physiol Biochem 1986; 4: 136-42.
37. Iovanna JL, Keim V, Nordback I, et al. Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis. Gastroenterology 1994: 106: 728-34.
38. Kemppainen E, Sand J, Puolakkainen P, et al. Pancreatitis associated protein as an early marker of acute pancreatitis. Gut 1996; 39: 675-8.
39. Pezzilli R, Billi P, Migliori M, et al. Clinical value of pancreatitis-associated protein in acute pancreatitis. Am J Gastroenterol 1997; 92: 1887-90.
40. Pousette A, Fernstad R, Skoldefors H, et al. Novel assay for pancreatic cellular damage. 1. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein. Pancreas 1988; 3: 421-6.
41. Pousette A, Fernstad R, Skoldefors H, et al. A novel serum assay for pancreatic cellular damage. II. High tissue specificity of a pancreatic protein. Pancreas 1988; 3: 642-5.
42. Yamamoto KK, Pousette A, Chow P, et al. Isolation of a cDNA encoding a human serum marker for acute pancreatitis. Identification of a pancreas-specific protein as pancreatic procarboxypeptidase B. J Biol Chem 1992; 267: 2575-81.
43. Fernstad R, Pousette A, Carlstrom K, et al. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases. Pancreas 1990; 5: 42-9.
44. Nyberg G, Olausson M, Norden D, et al. Pancreas-specific protein: Monitoring in pancreas transplantation. Transplant Proc 1991; 23: 1604-5.
45. Fernstad R, Tyden G, Brattstrom C, et al. Pancreas-specific protein. New serum marker for graft rejection in pancreas-transplant recipients. Diabetes 1989; 38 S1: 55-6.
46. Printz H, Siegmund H, Wojte C, et al. "Human pancreas-specific protein" (procarboxypeptidase B): a valuable marker in pancreatitis? Pancreas 1995; 10: 222-30.
47. Chen CC, Wang SS, Chao Y, et al. Serum pancreas-specific protein in acute pancreatitis. Its clinical utility in comparison with serum amylase. Scand J Gastroenterol 1994; 29: 87-90.
48. Pezzilli R, Billi P, Plate L, et al. Human pancreas-specific protein/procarboxypeptidase B: a useful serum marker of acute pancreatitis. Digestion 1994; 55: 73-7.
49. Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998; 42: 97-102.
50. Appelros S, Lindgren S, Borgstrom A. Short and long term outcome of severe acute pancreatitis. Eur J Surg 2001; 167: 281-6.
51. Ohlsson K, Balldin G, Bohe M, et al. Pancreatic proteases and antiproteases in pancreatic disease; biochemical, pathophysiological and clinical aspects. Int J Pancreatol 1988; 3: S67-8.
52. Itkonen O, Koivunen E, Hurme M, et al. Time-resolved immunofluorometric assays for trypsinogen-1 and -2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115: 712-8.
53. Hedstrom J, Leinonen J, Sainio V, et al. Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum. Clin Chem 1994; 40: 1761-5.
54. Hedstrom J, Sainio V, Kemppainen E, et al. Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chem 1996; 42: 685-90.
55. Hedstrom J, Kemppainen E, Andersen J, et al. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis. Am J Gastroenterol 2001; 96: 424-30.
56. Sainio V, Puolakkainen P, Kemppainen E, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996; 31: 818-24.
57. Hurley PR, Cook A, Jehanli A, et al. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988; 111: 195-203.
58. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8.
59. Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21: 105-10.
60. Mayer J, Sumar N, Schoenberg MH, et al. A new immunoassay for I-Phospholipase A2 activation peptide PROP in acute inflammatory diseases. Eur Surg Res 1996; 28: 90.
61. Kemppainen E, Mayer J, Puolakkainen P, et al. Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg 2001; 88: 679-80.
62. Mayer J, Rau B, Schoenberg MH, et al. Mechanism and role of trypsinogen activation in acute pancreatitis. Hepatogastroenterology 1999; 46: 2757-63.
63. Banks PA. Acute and chronic pancreatitis. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. W.B. Saunders Company, Philadelphis, 1998. pp. 809-62.
64. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101: 782-785.
65. Mayer J, Rau B, Gansauge F, et al. Imflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-552.
66. McKay CJ, Gallagher G, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83: 919-923.
67. De Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83: 1071-1075.
68. De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83: 349-353.
69. Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999; 94: 213-218.
70. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-45.
71. 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995; 40: 2341-2348.
72. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992; 22: 200-203.
73. Norman JG, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 1996; 223: 163-169.
74. Heresbach D, Letourneur JP, Bahon I, et al. Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroenterol 1998; 33: 554-560.
75. Kaufmann P, Tilz GP, Lueger A, Demel U. Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis. Intensive Care Med 1997; 23: 841-848.
76. Hoffmann GE, Schmidt D, Bastian B, et al. Photometric determination of phospholipase A. J Clin Chem Clin Biochem 1986; 24: 871-5.
77. Schadlich HR, Buchler M, Beget HG. Improved method for the determination of phospholipase A2 catalytic activity concentration in human serum and ascites. J Clin Chem Clin Biochem 1987; 25: 505-9.
78. Makela A, Kuusi T, Somerharju P, et al. A simple isotopic assay method for human serum phospholipase A2 activity. Scand J Clin Lab Inv 1987; 47: 529-34.
79. Nevalainen TJ, Kortesuo PT, Rintala E, et al. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem 1992; 38: 1824-9.
80. Santavuori SA, Kortesuo FF, Eskola JU, et al. Application of a new monoclonal antibody for time-resolved fluoroimmunoassay of human pancreatic phospholipase A2. Eur J Clin Chem Clin Biochem 1991; 29: 819-26.
81. Buchler M, Malfertheiner P, Schadlich H, et al. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989; 97: 1521-6.
82. Gronroos JM, Nevalainen TJ. Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992; 52: 232-6.
83. Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34: 1133-6.
84. Makela A, Kuusi T, Schroder T. Serum phospholipase A2, amylase, lipase, and urinary amylase activities in relation to the severity of acute pancreatitis. Eur J Surg 1997; 163: 915-22.
85. Mayer J, Rau B, Grewe M et al. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 1998; 17: 272-7.
86. Gronroos JM, Hietaranta AJ, Nevalainen TJ. Renal tubular cell injury and serum phospholipase A2 activity in acute pancreatitis. Br J Surg 1992; 79: 800-1.
87. Gukovskaya AS, Vaquero E, Zaninovic V, et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 2002; 122: 974-84.
88. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991; 78: 1230-4.
89. Berney T, Gasche Y, Robert J, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 18: 371-7.
90. Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89: 93-104.
91. Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-40.
92. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431-5.
93. Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84: 1665-9.
94. Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg 1997; 132: 487-92.
95. Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176: 480-3.
96. Fan ST, Lai ECS, Mok FPT, et al. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993; 328: 228-32.
97. Neoptolemos JP, Carr-Locke DL, London NJ, et al. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988; 2: 979-83.